Influenza Diagnostics Market Analysis from 2025 to 2031

Posted 2026-02-06 17:53:16

27K

Market Overview

The Influenza Diagnostics Market focuses on detecting Influenza A and B using rapid tests, RT-PCR, immunoassays and point-of-care devices. These tools are used in hospitals, clinics, labs and homes to ensure early detection, appropriate treatment and outbreak control. Influenza’s global threat persists due to seasonal epidemics and pandemic potential. Market growth is driven by government preparedness programs, rising diagnostic awareness, technological advancements and expanding decentralized testing systems that improve timely respiratory disease surveillance.

Key Players

F HoffmannLa Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Becton Dickinson and Company, Quidel Corporation, Danaher Corporation, bioMrieux SA, Hologic Inc, Luminex Corporation, Meridian Bioscience Inc, GenMark Diagnostics, Sekisui Diagnostics, DiaSorin SpA, Cepheid Danaher, SA Scientific Ltd, Alere Inc, Merck KGaA, BioRad Laboratories Inc, Luminex Corporation, BioFire Diagnostics bioMrieux

Sample link - https://www.trendbridgeinsights.com/industry-report/influenza-diagnostics-market

Market segmentation:

Product Type

· Rapid Influenza Diagnostic Tests RIDT

· RTPCR

· Cell Culture

· Immunofluorescence Assay IFA

· Others

End User

· Hospitals

· Diagnostic Laboratories

· Research Institutes

· PointofCare Testing

· Others

Type of Influenza

· Influenza A

· Influenza B

· Influenza C

Technology

· Molecular Diagnostics

· Immunodiagnostics

· Nucleic Acid Amplification Tests NAAT

· Isothermal Nucleic Acid Amplification Technology INAAT

Mega Trend Connect:

This report offers deep insights into how mega trends such as digitalization, precision medicine, data-driven care delivery, and regulatory evolution are transforming medical devices. It further examines the impact of advanced technologies, platform-based models, automation, and interoperability across products and services within this segment. The report assesses regulatory complexity, adoption readiness, cost pressures, and ecosystem maturity shaping global market development.

Global Trade Outlook:

Global trade in medical devices is increasingly shaped by regulatory stringency, localization mandates, data sovereignty requirements, and public health policy priorities. Cross-border scalability is constrained by approval timelines, compliance variation, and infrastructure readiness, driving regionalized production, partnerships, and delivery models. Market access and competitiveness now depend on regulatory agility, localized execution, and compliance-by-design strategies.

Region Analysis :

North America leads the Influenza Diagnostics Market because it hosts major diagnostic manufacturers, advanced molecular testing systems, and strong government-funded surveillance programs. Europe follows with robust public health infrastructure and ECDC-supported preparedness. Asia-Pacific grows fastest, driven by rising influenza cases and expanding diagnostic capacity. Latin America and MEA advance steadily as outbreak management systems modernize and rapid PoC testing adoption increases.

Recent development :

In March 2025, The QuidelOrtho Corporation introduced its next-generation molecular flu test which detects influenza A/B and RSV within one cartridge. The high-sensitivity test functions to detect co-infections in urgent care facilities and primary care clinics.

FAQ:

1 . What is the Forecasted market size & CAGR of the Influenza Diagnostics Market ?

The global influenza diagnostics market achieved USD 1.52 billion in 2023 value while demonstrating a 7.1% compound annual growth rate to reach USD 1.63 billion in 2024 and USD 2.29 billion by 2029.

2. Who are the leading manufacturers and suppliers in the Influenza Diagnostics Market ?

F HoffmannLa Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Becton Dickinson and Company, Quidel Corporation, Danaher Corporation, bioMrieux SA, Hologic Inc

3. What are the upcoming trends of Influenza Diagnostics Market in the globe?

Rapid Point-of-Care (PoC) Testing: The demand for immediate influenza detection during outbreaks drives the growing adoption of point-of-care diagnostics. Rapid diagnostic tests (RDTs) have become popular in clinics and pharmacies and remote locations because they enhance both accessibility and response speed. The segment advances through the efforts of Abbott and Quidel as well as other companies.

4. Which is the largest regional market for Influenza Diagnostics Market ?

The market leadership of North America stems from its developed healthcare system and high population awareness about influenza together with its strong influenza outbreak surveillance programs.

About US: